|The Microbiology and Molecular Diagnostics department utilizes cutting edge methods, technologies, and automation to provide accurate and timely patient care. The department has successfully incorporated a number of molecular diagnostic tests to greatly improve analytic sensitivity and specificity, as well as turnaround time for result reporting.
As leaders in infectious disease molecular testing for transplant patients, our department provides the tools to help monitor disease states that can be rapidly devastating to this patient population. We also provide highly sensitive testing, with optimal turnaround time, to monitor patients with HIV and Hepatitis B and C.
We have made significant advances in testing patients for the presence of septicemia utilizing molecular-based testing. This has decreased the time to identification from 1-3 days to 2 hours. For respiratory testing, we provide cutting edge technology for influenza and other important respiratory pathogens.
Our department also led the charge in the United States in the use of Matrix Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry for organism identification. We are one of the first laboratories to use MALDI-TOF as the primary identification method for all organisms, including aerobic/anaerobic bacteria, mycobacteria, and fungi. Transitioning to this method had vastly improved accurate identifications while greatly reducing turnaround time.
For Additional Information, Please Contact:
Nathan Ledeboer, PhD, D(ABMM)
Medical Director, Microbiology and Molecular Diagnostics
Blake Buchan, PhD, D(ABMM)
Associate Medical Director, Microbiology and Molecular Diagnostics
Kristina Georgakas MT(ASCP)
Operations Director, Microbiology and Molecular Diagnostics